Links are not yet activated.
Is this your press release? Add a link to submitpr.org on your website and verify it — activation is instant and free.
Or upgrade with KIN for permanent activation (from $19.95).
LegaLogic announced that it advised Sava Healthcare Limited on the sale of its companion animal business, operating under the SAVAVET brand, to Zenex Animal Health India Private Limited. Zenex is backed by private equity firm Multiples Alternate Asset Management.SAVAVET is among India’s leading companion animal healthcare businesses. It sells around 70 brands across parasiticides, antibiotics, cardiac care, pain management, dermatology and wellness, through about 165 stockists, and works with more than 6,000 veterinarians nationwide. Companion animal healthcare is one of the fastest growing segments of animal health in India, and the acquisition gives Zenex immediate scale through SAVAVET’s strong portfolio, established market presence and veterinarian network.
Following the transaction, Sava Healthcare Limited will focus on human health formulations, pharmaceutical research and development, contract manufacturing and its international business. Sava will also retain its farm animal business and continue manufacturing agreed products under contract manufacturing arrangements.
LegaLogic was the sole legal counsel for Sava Healthcare Limited. It advised on the review, negotiation and finalisation of the deal documentation and on the closing of the transaction.
Commenting on LegaLogic’s role, Mr. Karthik Rajan, CEO and Executive Director, Sava Healthcare Limited, said: “LegaLogic’s sharp legal foresight and meticulous counsel were instrumental in navigating high-stakes negotiations, steering complex buyer side counsel interactions and ensuring a fully protected, successful transaction.”
For more information, visit www.legalogic.com.